Matches in Wikidata for { <http://www.wikidata.org/entity/Q63806643> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q63806643 description "clinical trial" @default.
- Q63806643 description "ensayu clínicu" @default.
- Q63806643 description "klinisch onderzoek" @default.
- Q63806643 description "клінічне випробування" @default.
- Q63806643 name "ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA" @default.
- Q63806643 type Item @default.
- Q63806643 label "ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA" @default.
- Q63806643 prefLabel "ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA" @default.
- Q63806643 P1132 Q63806643-710F1E20-4D08-4013-B90B-3A5D9458D41B @default.
- Q63806643 P131 Q63806643-23F5CBDB-786B-4E1E-B243-D12357ECF85C @default.
- Q63806643 P1476 Q63806643-9D1FE8E5-B166-4E86-9B92-FE7BFF09925B @default.
- Q63806643 P17 Q63806643-0FE13207-A714-4871-800C-4C9866248BB9 @default.
- Q63806643 P2899 Q63806643-9CD92797-D23A-4A4A-B119-7276B15B7463 @default.
- Q63806643 P3098 Q63806643-E20099D9-6D3B-4838-9BE6-4BEA756BCAC2 @default.
- Q63806643 P31 Q63806643-6A99B3F1-96FB-4043-8B8A-5ED651418E67 @default.
- Q63806643 P4135 Q63806643-48C1F0D9-98D5-4E3F-A8C0-9E3959843F9B @default.
- Q63806643 P4844 Q63806643-5C4A5A5C-C6DA-4F2D-8E91-581AEF45BBFB @default.
- Q63806643 P580 Q63806643-412C3FDD-79F3-4A1F-A163-685B0C4C4011 @default.
- Q63806643 P582 Q63806643-3B51F001-DADC-4B86-B9CB-D3ED3E83BDE5 @default.
- Q63806643 P6099 Q63806643-BB8EC88D-3558-414A-AA80-059065CE74C2 @default.
- Q63806643 P8363 Q63806643-1F1AA0E8-78FF-474D-8827-7993206053D0 @default.
- Q63806643 P859 Q63806643-D0E390B1-6F1A-4852-A25A-85CDB0B9A526 @default.
- Q63806643 P1132 "+264" @default.
- Q63806643 P131 Q8646 @default.
- Q63806643 P1476 "Histamine-2 Receptor Antagonist Versus Proton-Pump Inhibitor for the Prevention of Recurrent Upper Gastrointestinal Bleeding (UGI) in High-risk Users of Low-dose Aspirin (ASA)" @default.
- Q63806643 P17 Q17 @default.
- Q63806643 P2899 "+18" @default.
- Q63806643 P3098 "NCT01408186" @default.
- Q63806643 P31 Q30612 @default.
- Q63806643 P4135 "+99" @default.
- Q63806643 P4844 Q3515 @default.
- Q63806643 P580 "2011-01-01T00:00:00Z" @default.
- Q63806643 P582 "2015-11-01T00:00:00Z" @default.
- Q63806643 P6099 Q42824827 @default.
- Q63806643 P8363 Q78089383 @default.
- Q63806643 P859 Q15570 @default.